This website houses recordings of the sponsored symposia that Alexion presented at EAN 2025 in Helsinki.

Feel free to watch the educational recordings reviewing the latest clinical and real-world evidence of complement inhibitors in neuromyelitis optica spectrum disorder (NMOSD) and generalized myasthenia gravis (gMG).

These presentations are organised and funded by Alexion, AstraZeneca Rare Disease and intended for Healthcare Professionals. Alexion products will be discussed during these events. Please note that registration conditions and product availability may vary internationally. Please refer to your local prescribing information or contact your local Alexion affiliate for further information.